Maintenance of Remission with Etanercept–DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis

類似資料

• Maintenance of low disease activity and remission with etanercept–disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis of a randomized trial
  著者:: Zerbini, Cristiano A.F., 等
  出版事項: (2018)
• Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis
  著者:: Bae, Sang-Cheol, 等
  出版事項: (2013)
• Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
  著者:: Gashi, Afrim A., 等
  出版事項: (2014)
• The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
  著者:: Yoshiya Tanaka, 等
  出版事項: (2019-07-01)
• The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
  著者:: Tanaka, Yoshiya, 等
  出版事項: (2019)